title: Gene delivery to the myocardium by intrapericardial injection.
abstract: Several studies have demonstrated the feasibility of gene transfer into the heart muscle. However, all the available data also indicate that the extent of transfection remains limited. As an alternative method to intravascular administration, we have developed a novel strategy which uses the pericardial sac. When a replication-deficient adenovirus containing the cDNA encoding a bacterial beta-galactosidase is injected into the pericardial sac of adult Wistar rats the staining is exclusively restricted to the pericardial cell layers. However, injecting a mixture of collagenase and hyaluronidase together with the virus, leads to a large diffusion of the transgene activity, reaching up to 40% of the myocardium. Transgene expression is predominant in the left ventricle and the interventricular septum but limited in the right ventricle. In vivo echocardiographic measurements of the left ventricular diameters at end diastolic and end systolic times show no difference between virus- and sham-injected animals, thus indicating a good clinical tolerance to this strategy of virus delivery. The same protocol has been used with the same efficiency in mice, which leads us to propose injection into the pericardial sac as an effective and harmless method for gene transfer into the heart muscle.
authors.affiliation: INSERM U153-Institut de Myologie, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Fromes
authors.forename: A
authors.initials: A
authors.lastname: Salmon
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: H
authors.initials: H
authors.lastname: Collin
authors.forename: A
authors.initials: A
authors.lastname: Rouche
authors.forename: A
authors.initials: A
authors.lastname: Hagège
authors.forename: K
authors.initials: K
authors.lastname: Schwartz
authors.forename: M Y
authors.initials: MY
authors.lastname: Fiszman
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D017364:Collagenases / Q000008:administration & dosage; D016616:Cryoultramicrotomy; D004452:Echocardiography; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage* / Q000235:genetics; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage; D007267:Injections; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009206:Myocardium; D010447:Peptide Hydrolases / Q000008:administration & dosage*; D010496:Pericardium; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D014162:Transfection / Q000379:methods*; D001616:beta-Galactosidase / Q000235:genetics
chemical_list: D001616:beta-Galactosidase; D006821:Hyaluronoglucosaminidase; D010447:Peptide Hydrolases; D017364:Collagenases